GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » HST Global Inc (OTCPK:HSTC) » Definitions » EV-to-EBIT

HST Global (HST Global) EV-to-EBIT : -41.93 (As of May. 11, 2024)


View and export this data going back to 2002. Start your Free Trial

What is HST Global EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, HST Global's Enterprise Value is $5.87 Mil. HST Global's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.14 Mil. Therefore, HST Global's EV-to-EBIT for today is -41.93.

The historical rank and industry rank for HST Global's EV-to-EBIT or its related term are showing as below:

HSTC' s EV-to-EBIT Range Over the Past 10 Years
Min: -43.8   Med: 0   Max: 9.92
Current: -41.93

During the past 13 years, the highest EV-to-EBIT of HST Global was 9.92. The lowest was -43.80. And the median was 0.00.

HSTC's EV-to-EBIT is ranked worse than
100% of 433 companies
in the Biotechnology industry
Industry Median: 9.43 vs HSTC: -41.93

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. HST Global's Enterprise Value for the quarter that ended in Dec. 2023 was $3.28 Mil. HST Global's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.14 Mil. HST Global's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -4.26%.


HST Global EV-to-EBIT Historical Data

The historical data trend for HST Global's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HST Global EV-to-EBIT Chart

HST Global Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.14 -1.94 -4.33 -5.01 -23.29

HST Global Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -5.01 -4.26 -6.31 -20.28 -23.29

Competitive Comparison of HST Global's EV-to-EBIT

For the Biotechnology subindustry, HST Global's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


HST Global's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, HST Global's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where HST Global's EV-to-EBIT falls into.



HST Global EV-to-EBIT Calculation

HST Global's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=5.870/-0.14
=-41.93

HST Global's current Enterprise Value is $5.87 Mil.
HST Global's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.14 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


HST Global  (OTCPK:HSTC) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

HST Global's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 ) =EBIT / Enterprise Value (Q: Dec. 2023 )
=-0.14/3.28451235
=-4.26 %

HST Global's Enterprise Value for the quarter that ended in Dec. 2023 was $3.28 Mil.
HST Global's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.14 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


HST Global EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of HST Global's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


HST Global (HST Global) Business Description

Traded in Other Exchanges
N/A
Address
150 Research Drive, Hampton, VA, USA, 23666
HST Global Inc is an integrated health and wellness biotechnology company. It is engaged in developing and acquiring a network of Wellness Centers that are focused on the homeopathic and alternative treatment of late-stage cancer. Further, it primarily focuses on homeopathic and alternative product candidates that are undergoing or have already completed clinical testing. The activities are generally carried out through the region of the United States.
Executives
Wesley D. Tate officer: CFO and Secretary C/O HEALTH SOURCE TECHNOLOGIES, INC., 150 RESEARCH DRIVE, HAMPTON VA 23666
Ronald R. Howell director, officer: CEO and Chairman C/O HEALTH SOURCE TECHNOLOGIES, INC., 150 RESEARCH DRIVE, HAMPTON VA 23666
Pnc Labs Inc 10 percent owner 429 W PLUMB LANE, RENO NV 89509
Chun Ka Tsun director, 10 percent owner, officer: CEO TG WANASPORTS MANAGEMENT HOLDINGS, 8/F NO 211 JOHNSTON ROAD, WAN CHAI K3 00000
Chen Tsz King 10 percent owner FUGU ENTERPRISE INC, UNIT A 8TH FLOOR NO 65 SING WOOD ROAD, HAPPY VALLEY K3 00000
Li Sze Tang 10 percent owner FLAT G, 8/FL TOWER THREE, THE WATERFRONT, 1 AUSTIN ROAD WEST, TST K3 00000
Andre E Todd director 746 HILLGIRT CIRCLE, OAKLAND CA 94610
Aaron Etra director 1350 AVE OF AMERICAS, 29TH FLOOR, NEW YORK NY 10019
Communications Holding Corp 10 percent owner
Alan Lew director, 10 percent owner, officer: President 2 DOGWOOD DR, SCARSDALE NY 10583

HST Global (HST Global) Headlines